Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

Completed · Phase 2

Conditions studied: Liver Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as irinotecan and flavopiridol, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving irinotecan together with flavopiridol works in treating patients with advanced liver cancer.

Key facts

Study ID

NCT00087282

Run by

Memorial Sloan Kettering Cancer Center

Starts

2004-06-01

Expected to finish

2006-07-01

Last updated by the study team

2013-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.